Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study.
Saved in:
| Title: | Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study. |
|---|---|
| Authors: | Agiro A; AstraZeneca, US Medical Affairs, 1800 Concord Pike, Wilmington, DE, 19850, USA. abiy.agiro@astrazeneca.com., An A; University of California Irvine, Irvine, CA, 92697, USA., Cook EE; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA., Mu F; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA., Chen J; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA., Desai P; AstraZeneca, US Medical Affairs, 1800 Concord Pike, Wilmington, DE, 19850, USA., Oluwatosin Y; AstraZeneca, US Medical Affairs, 1800 Concord Pike, Wilmington, DE, 19850, USA., Pollack CV Jr; University of Mississippi, Jackson, MS, 38677, USA. |
| Source: | Advances in therapy [Adv Ther] 2023 Jun; Vol. 40 (6), pp. 2886-2901. Date of Electronic Publication: 2023 May 04. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
